Daniel Paul Regan serves as Executive at INTERCEPT PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Daniel Paul Regan has executed 58 insider transactions totaling $13.3M, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 5, 2014 involved selling 1,288 shares valued at $568.8K.
Daniel Paul Regan currently holds 60,000 shares of INTERCEPT PHARMACEUTICALS INC (ICPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel Paul Regan has been a net seller of ICPT stock. They have purchased $0 and sold $13.3M worth of shares.
Daniel Paul Regan's most recent insider trade was on Mar 5, 2014, when they sold 1,288 shares at $441.59 per share.
Get notified when new Form 4 filings are submitted
| $442.49 |
| Discretionary |
| Mar 5, 2014 | ICPT | $753.8K | Option Exercise | 20,000 | $37.69 | Discretionary |
| Mar 5, 2014 | ICPT | $213.0K | Sale | 500 | $426.06 | Discretionary |
| Mar 5, 2014 | ICPT | $213.5K | Sale | 500 | $427.05 | Discretionary |
| Mar 5, 2014 | ICPT | $300.0K | Sale | 700 | $428.51 | Discretionary |
| Mar 5, 2014 | ICPT | $746.2K | Sale | 1,724 | $432.84 | Discretionary |
| Mar 5, 2014 | ICPT | $146.2K | Sale | 339 | $431.34 | Discretionary |